CONCLUSION:

SCO of the ribs is exceptional and should be kept in mind in the management of ribs’ tumors. Early diagnosis is important for better-improved prognosis. The integration of clinical, radiologic, pathologic, and ancillary test results, including immunohistochemical and molecular results is necessary to establish the right diagnosis. Surgical resection is the only curative treatment and it should be as complete as possible. Adjuvant chemotherapy may improve survival despite the poor prognosis of this aggressive type of bone malignant tumors.
REFERENCES:
  1. WHO Classification of Tumors Editorial Board eds. World Health Organization classification of soft tissue and bone tumors. 5th edition. Lyon: IARC Press, 2020.
  2. Martin SE, Dwyer A, Kissane JM, Costa J. Small-cell osteosarcoma. Cancer 1982; 50: 990-6.
  3. Devaney K, Vinh TN, Sweet DE. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations. Hum Pathol 1993; 24: 1211-25.
  4. Göktürk Fındık, Ersin Günay, Yetkin Ağaçkıran, Koray Aydoğdu, Ertan Aydın, Sadi Kaya. Small cell osteosarcoma of rib: diagnosis and treatment of the rare case. Tuberk Toraks 2012; 60: 172-5.
  5. S H Park, I Kim. Small cell osteogenic sarcoma of the ribs: cytological, immunohistochemical, and ultrastructural study with literature review. Ultrastruct Pathol 1999; 23: 133-40.
  6. Lushiku HB, Gebhart M. Osteosarcoma of the proximal fibula: report of 3 cases. Acta Chir Belg 1997; 97: 260-3.
  7. Dickersin GR, Rosenberg AE. The ultrastructure of small-cell osteosarcoma, with a review of the light microscopy and differential diagnosis. Hum Pathol 1991; 22: 267-75.
  8. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience. Cancer 1992; 69: 698-708.
ANNEXES: